![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > The Netherlands
Find below all kinds of persons from the Netherlands or working for Dutch organisations.Total search results: 705 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Aarts, Kees (Protix 202202 CEO + Founder) | Chief Executive Officer (CEO) | Protix B.V. | Netherlands_o |
| Abbott, Rachel (Pan Cancer T 202305– CEO joined as CSO 1/23 before Enara Bio + Adaptimmune) | Chief Executive Officer (CEO) | Pan Cancer T B.V. | South Holland (province, NL) |
| Ahmati, Besmire (Gilde Investment 202306– Associate IR + Fundraising at Gilde Healthcare before PGGM + FMO) | Public Relations Manager / Investor Relations Manager | Gilde Investment (Group) | Netherlands_o |
| Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) | Chief Executive Officer (CEO) | Hookipa (Group) | Wien (state) |
| Allen, Debbie (Argen-X 201204 Senior Director Business Development) | Business Development Manager / Strategy Manager | Argenx (Argen-X) (Group) | North Brabant (province, NL) |
| Altink, Alexander (Kreatech 2000– CEO before van Ommeren & Ceteco) | Chief Executive Officer (CEO) | Danaher (Group) | North Holland (province, NL) |
| Amar, Frédéric (Esperite 201801 CEO) | Chief Executive Officer (CEO) | Esperite (Group) | Netherlands_o |
| Andersen, Bente Korsgaard (The Protein Brewery 202209 Board Chair) | Board member, non-executive | The Protein Brewery B.V. (TPB) | North Brabant (province, NL) |
| Andersen, Peter Høngaard (Forbion 202207– Operating Partner before Lundbeck + Novo Nordisk et al) | Partner (venture partner) | Forbion (Group) | North Holland (province, NL) |
| Aranowska-Bablok, Anna (Joint Polish Investment Fund 201503 General Partner) | General Partner (venture partner) | Joint Polish Investment Fund (JPIF) (Group) | Netherlands_o |
| Arnold, Jonathan (Qiagen 201606 Oncology Franchise Leader) | Product Manager (personnel) | Qiagen (Group) | Limburg (province, NL) |
| Asbjornsen, Laura (Forbion 202104– Head of Communications) | Public Relations Manager / Investor Relations Manager | Forbion (Group) | North Holland (province, NL) |
| Aspinall, Adam (Norgine 201107– Global Marketing Director before Amgen International Marketing Manager in Zug) | Sales Manager / Marketing Manager | Norgine (Group) | North Holland (province, NL) |
| Astley-Sparke, Philip (Forbion 201209– Venture Partner before Amgen + BioVex CEO since 2005 + JP Morgan) | Venture Partner | Forbion (Group) | North Holland (province, NL) |
| Atrzadeh, Faranak (Curetis 201904 SVP Scientific Affairs + Marketing) | Sales Manager / Marketing Manager | OpGen (Group) | North Holland (province, NL) |
| Audet, Juliette (Forbion 202108 Partner) | Partner (venture partner) | Forbion (Group) | North Holland (province, NL) |
| Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) | Principal (venture capital) | Illumina (Group) | California (federal state) |
| Avery, Jason (Merus 201206– CBO before Affitech Head Bus Dev + Cambridge Antibody Technology CBO) | Chief Business Officer (CBO) | Merus (Group) | Netherlands_o |
| Baijens, Ruben (Eindhoven Venture Capital Fund II 201903 Investment Director) | Investment Manager | Eindhoven Venture Capital Fund II (EVCF II) | North Brabant (province, NL) |
| Baldo, Marjolaine (Agendia 201712 Commercial VP EMEA) | Sales Manager / Marketing Manager | Agendia (Group) | North Holland (province, NL) |
| Balkema, Jurjen (Westburg BV 201307 Commercial Director + Co-owner) | Chief Commercial Officer (CCO) | Westburg (Group) | Utrecht (province, NL) |
| Ballesteros, Kathrin (NLC Ventures 202111 Venture Partner formerly KBK Concept 201310) | Partner (venture partner) | NLC Ventures (Group) | North Holland (province, NL) |
| Barbetsea, Kassandra (Lumicks 202104 PR + Marketing) | Sales Manager / Marketing Manager | Lumicks (Group) | North Holland (province, NL) |
| Bardin, Stephen (Atai Life Sciences 202206– Deputy CFO + CFO Designate before BridgeBio Pharma + Myovant Sciences) | Chief Financial Officer (CFO) | Atai Life Sciences (Group) | Netherlands_o |
| Barél, Erna (BaseClear 1993– Managing Director + Founder) | Managing Director | BaseClear B.V. | South Holland (province, NL) |
| Bartlema, Gertjan (Vico Therapeutics 202007 CBO) | Chief Business Officer (CBO) | Vico Therapeutics B.V. | South Holland (province, NL) |
| Bartonícek, Ladislav (PPF Group 201502 Board Member responsible for biotechnology) | Board member, executive | PPF Group (Group) | North Holland (province, NL) |
| Bath, Christopher (Norgine 201705 CFO) | Chief Financial Officer (CFO) | Norgine (Group) | North Holland (province, NL) |
| Bechu, Sophie (Philips 201609– EVP + Chief of Operations before IBM for over 30 years) | Chief Operating Officer (COO) | Philips (Group) | North Brabant (province, NL) |
| Beck, Nico (Spark Holland 201003 OEM Technical Support Specialist) | Technical Manager | Spark Holland (Group) | Drenthe (province) |
| Been, Kees (Kynexis 202311– CEO formerly EnVivo 200506– CEO before Bionaut CEO + Biogen) | Chief Executive Officer (CEO) | Kynexis (Group) | North Holland (province, NL) |
| Beijersbergen van Henegouwen, Hans (Isogen Life Science 200611) | n. a. | Isogen Life Science (NL) | Netherlands_o |
| Bender, Richard A. (Agendia 200804– VP + CMO before Spectrum Pharma) | Chief Medical Officer (CMO) | Agendia (Group) | North Holland (province, NL) |
| Berger, Pim (Amarna Therapeutics 201910– Supervisory Board Member + existing investor) | Supervisory Board Member | Amarna Therapeutics B.V. | South Holland (province, NL) |
| Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations) | President/Director/Head Business Group/Unit/Division | Qiagen (Group) | Limburg (province, NL) |
| Bernards, René (Agendia 201110 CSO + Co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Agendia (Group) | North Holland (province, NL) |
| Berninger, Harald (Kreatech 200709– Sales + Marketing Director before Qiagen since 1993) | Sales Manager / Marketing Manager | Danaher (Group) | North Holland (province, NL) |
| Beudeker, Rob (DSM 201902 Investment Director at DSM Venturing) | Investment Manager | DSM (Group) | Limburg (province, NL) |
| Bhattacharya, Abhijit (Philips 201707–202409 CFO RETIRED 10724) | Chief Financial Officer (CFO) | Philips (Group) | North Brabant (province, NL) |
| Bielefeld-Sévigny, Martina (PerkinElmer 200401– VP drug discovery + research reagents before DSM Biologics) | General Manager (management) | PerkinElmer (Group) | Massachusetts (federal state) |
| Bilars, Paul (NecstGen 202204 CEO formerly VarmX BV 201706 CEO) | Chief Executive Officer (CEO) | NecstGen (Netherlands Center for the Clinical Advancement of Stem Cell & Gene Therapies) | South Holland (province, NL) |
| Binnema, Doede (Healthy Ageing Network Northern Netherlands 201109 Program Manager Food & Nutrition) | Cluster Manager | Healthy Ageing Network Northern Netherlands (HANNN) | Groningen (province) |
| Blauw, Lisanne (River BioMedics 202307 COO + Co-Founder) | Chief Operating Officer (COO) | Thuja Capital (Group) | Netherlands_o |
| Boorsma, Marco (Forbion Capital Partners 201302) | Partner (venture partner) | Forbion (Group) | North Holland (province, NL) |
| Borchards, Nadia (Synexa Life Sciences 202205c– CFO) | Chief Executive Officer (CEO) | Synexa Life Sciences (Group) | South Holland (province, NL) |
| Borellini, Flavia (AstraZeneca 201708 CEO of Acerta Pharma) | Chief Executive Officer (CEO) | AstraZeneca (Group) | North Brabant (province, NL) |
| Bormann, B. J. (Harbour Antibodies BV 201307– CEO before Boehringer Ingelheim + Pfizer) | Chief Executive Officer (CEO) | Harbour BioMed (Group) | South Holland (province, NL) |
| Boronowsky, Ute (Cube Biotech 201207– Managing Director before Qiagen) | Managing Director | Qiagen (Group) | Limburg (province, NL) |
| Bos, Harry (Sanguin Blood Supply 201409 Director of Diagnostics) | n. a. | Sanquin (Group) | North Holland (province, NL) |
| Bos, Jasper (Forbion 202105 General Partner before M Ventures + Netherlands Vaccine Institute) | General Partner (venture partner) | Forbion (Group) | North Holland (province, NL) |
| Bosch, Lindy (SMS-Oncology 201602 Business Developer) | Business Development Manager / Strategy Manager | Cato SMS (Group) | North Holland (province, NL) |
| Bosch, Maarten (Mosa Meat 202009 CEO) | Chief Executive Officer (CEO) | Mosa Meat B.V. | Limburg (province, NL) |
| Botma, Jetze (KIESTRA Lab Automation 201004 CEO) | Chief Executive Officer (CEO) | Becton, Dickinson (Group) | Frieslân (province) |
| Botti, Jean (Philips 201604– Chief Innovation + Strategy Officer before Airbus Group + Renault + General Motors) | Corporate Strategy Manager | Philips (Group) | North Brabant (province, NL) |
| Botti, Simone (Inkef Capital 202104 Junior Partner before Metabomed + MS Ventures Israel Bioincubator Fund) | Partner (venture partner) | ABP (Stichting Pensioenfonds) (Group) | North Holland (province, NL) |
| Boujnah, Stéphane (Euronext 201711 CEO) | Chief Executive Officer (CEO) | Euronext (Group) | North Holland (province, NL) |
| Bouman, Manja (Kiadis 200707 CEO) | Chief Executive Officer (CEO) | Kiadis (Group) | Groningen (province) |
| Bout, Bram (ProFibrix BV 200703– CTO before Crucell VP Protein Production) | Research & Development Manager | Novartis (Group) | South Holland (province, NL) |
| Brandt, Remco M. (Bioceros 200805 COO) | Chief Operating Officer (COO) | Polpharma (Group) | Netherlands_o |
| Breimer, Douwe | Board member, non-executive | EQT (Wallenberg family) (Group) | North Holland (province, NL) |
| Brichard, Vincent (Life Sciences Partners 2016– Venture Partner before GSK SVP + Head of Immunotherapeutics) | Partner (venture partner) | EQT (Wallenberg family) (Group) | North Holland (province, NL) |
| Briejer, Michel (Thuja Capital 201905 Managing Partner) | Managing Partner (investment firm) | Thuja Capital (Group) | Netherlands_o |
| Briman, Yair (Philips 201711 Business Leader Healthcare Informatics) | Chief Business Officer (CBO) | Philips (Group) | North Brabant (province, NL) |
| Broer, Wim (Cotecna 201712 Manager Developm + Science at NofaLab) | n. a. | Cotecna (Group) | South Holland (province, NL) |
| Broja, Christoph (EQT 202306 Managing Director at EQT Life Sciences) | Managing Director | EQT (Wallenberg family) (Group) | North Holland (province, NL) |
| Brunen, Diede (BioGeneration Ventures 202307– promoted to Principal joined BGV 11/2017 as Analyst) | Principal (venture capital) | BioGeneration Ventures B.V. (BGV) | North Holland (province, NL) |
| Brunswiek, Soenke (PharmCell 201501 Director Business Development) | Business Development Manager / Strategy Manager | Lonza (Group) | Limburg (province, NL) |
| Brus, Ronald (Crucell 200401 CEO) | Chief Executive Officer (CEO) | Johnson & Johnson (JnJ) (Group) | South Holland (province, NL) |
| Bräuer, Philipp (EQT 202210 Associate at EQT Life Sciences) | Associate (venture capital) | EQT (Wallenberg family) (Group) | North Holland (province, NL) |
| Buechner, Ton (Akzo Nobel 201511 CEO + Novartis 201602– Board Director PROPOSED) | Chief Executive Officer (CEO) | Akzo Nobel (Group) | Gelderland (province) |
| Buitelaar, Nettie (Leiden Bioscience Park 201104 CEO) | Chief Executive Officer (CEO) | Leiden Bio Science Park Foundation | South Holland (province, NL) |
| Bulthuis, Roel (Syncona 202304– Managing Partner before Inkef Capital + M Ventures + Merck Serono + Fortis Bank) | Managing Partner (investment firm) | Syncona (Group) | Greater London (region) |
| Burdon, Drew (Life Sciences Partners 201201 Investment Manager) | Investment Manager | EQT (Wallenberg family) (Group) | North Holland (province, NL) |
| Burton, Deborah (Da Vinci Group 201212 Managing Director of TransGlobal Distributors BV) | Managing Director | Da Vinci (Group) | South Holland (province, NL) |
| Böhm, Christian (NLC Venture 202210 Venture Partner) | Venture Partner | NLC Ventures (Group) | North Holland (province, NL) |
| Campion, Giles (Prosensa 201309 CMO) | Chief Medical Officer (CMO) | BioMarin (Group) | South Holland (province, NL) |
| Carle, Vanessa (Forbion 202203– Associate before PharmaVentures + EPFL) | venture capital | Forbion (Group) | North Holland (province, NL) |
| Carter, Alan B. (Agendia 200902 VP BusDev before BioTrove + Celera + ABI + Perkin Elmer) | Business Development Manager / Strategy Manager | Agendia (Group) | North Holland (province, NL) |
| Cascella, Robert (Philips SVP Diagnosis + Treatment business before Hologic CEO) | Chief Executive Officer (CEO) | Philips (Group) | North Brabant (province, NL) |
| Casson, Duncan (Kymab 201303– Chief Developm Officer before PanGenetics COO + CAT + Genzyme) | Research & Development Manager | Sanofi (Group) [since May 2011] | East of England (region) |
| Castaldi, Eric (Argen-X 201406–202106 CFO before NicOx CFO LEFT 7/21) | Chief Financial Officer (CFO) | Argenx (Argen-X) (Group) | North Brabant (province, NL) |
| Cautreels, Werner (Selecta Biosciences 2012 CEO before CEO of Solvay Pharmaceuticals before Sanofi + Sterling-Winthrop) | Chief Executive Officer (CEO) | Selecta Biosciences (Group) | Massachusetts (federal state) |
| Chahal, Dharminder S. (SkylineDx 201309– CEO + Co-Founder + 202011 Investment Manager at Van Herk) | CEP-1347–Parkinson (LRC) | SkylineDx B.V. | South Holland (province, NL) |
| Chan, Karen (BioGeneration Ventures 202307– Associate before M Ventures) | Principal (venture capital) | BioGeneration Ventures B.V. (BGV) | North Holland (province, NL) |
| Chotoe, Justin (Biotactial 202403 COO + Co-Founder) | Chief Operating Officer (COO) | Biotactial (Group) | South Holland (province, NL) |
| Christ, Arnd (Immatics 202010– CFO before InflaRx + Proteros + MediGene + NovImmune + Probiodrug + Hoechst) | Chief Financial Officer (CFO) | Immatics (Group) | Netherlands_o |
| Cimino, Maryann (IO Biotech 202308 Director IR before Kiadis) | Public Relations Manager / Investor Relations Manager | IO Biotech (Group) | New York (federal state) |
| Claassen, Eric | Board member, non-executive | AM-Pharma (Group) | Utrecht (province, NL) |
| Clement, Tom (Qiagen 200901– VP Regulatory and Clinical Affairs before Roche + bioMérieux + Amersham) | Regulatory Affairs Manager | Qiagen (Group) | Limburg (province, NL) |
| Cobben, Hans (Bluebee 201603 CEO) | Chief Executive Officer (CEO) | Illumina (Group) | Netherlands_o |
| Comijn, Joke (Argen-X 201704 Corp Communications Manager) | Public Relations Manager / Investor Relations Manager | Argenx (Argen-X) (Group) | North Brabant (province, NL) |
| Cooper, Nicky (River BioMedics 202307 CEO) | Chief Executive Officer (CEO) | River BioMedics B.V. | Overijssel (province, NL) |
| Corzo, Deya (Sigion Therapeutics 201811– CMO before Sojournix + Uniqure + Celgene + Millennium + Genzyme) | Chief Medical Officer (CMO) | Uniqure (Group) | North Holland (province, NL) |
| Crowley, John (Merus 201611– CFO based in US before Charles River + Vertex + Sunovian) | Chief Financial Officer (CFO) | Merus (Group) | Netherlands_o |
| Crutchfield, Brad (Qiagen 201506–2016 SVP before Illumina + NanoString + Bio-Rad STEPPED DOWN 2016) | President/Director/Head Business Group/Unit/Division | Qiagen (Group) | Limburg (province, NL) |
| Dalstra, Annecke (KIESTRA Lab Automation 201004) | n. a. | Becton, Dickinson (Group) | Frieslân (province) |
| Dasberg, David (Facio Therapies 201504 Managing Director) | Managing Director | Facio Therapies B.V. | Netherlands_o |
| Davidson, Michael (NewAmsterdam Pharma 202008 CEO before Corvidia Therapeutics) | Chief Executive Officer (CEO) | NewAmsterdam Pharma B.V. (NAP) | North Holland (province, NL) |
| de Backer, Hans (Pepscan 202306 CEO) | Chief Executive Officer (CEO) | Biosynth (since 9/22) (Group) | Flevoland (province) |
| de Boer, Daniel A. (ProQR Therapeutics 201408 CEO) | Chief Executive Officer (CEO) | ProQR Therapeutics (Group) | South Holland (province, NL) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
